Elobixibat
Elobixibat (A 3309) is a potent and selective ileal bile acid transporter (IBAT) inhibitor with IC50 values of 0.13 nM (mouse), 0.53 nM (human), and 5.8 nM (canine) . This investigational compound is utilized in preclinical and clinical research for studying chronic idiopathic constipation and related gastrointestinal motility disorders.
Product Specifications
CAS Number
439087-18-0
Product Name Alternative
Mouse IBAT, Elobixibat, IBAT, human IBAT, A 3309, A3309, A-3309, AZD 7806, AZD7806, AZD-7806, canine IBAT
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
97.43% (May vary between batches)
Solubility
DMSO:225 mg/mL (323.33 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (7.19 mM)
Smiles
CCCCC1 (CCCC) CN (c2ccccc2) c2cc (SC) c (OCC (=O) N[C@@H] (C (=O) NCC (O) =O) c3ccccc3) cc2S (=O) (=O) C1
Molecular Formula
C36H45N3O7S2
Molecular Weight
695.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CEL (Bile Salt-activated Lipase, BAL, Bile Salt-stimulated Lipase, BSSL, Bucelipase, Carboxyl Ester Lipase, Cholesterol Esterase, Pancreatic Lysophospholipase, Sterol Esterase, BAL) (PE)
Vinexin (SORBS3) Human qPCR Template Standard (NM_001018003)
